Psilox Overview

  • Founded

  • 2013

Founded
  • Status

  • Private

  • Employees

  • 5

Employees
  • Latest Deal Type

  • Later Stage VC

  • Latest Deal Amount

  • $625K

  • Investors

  • 4

Psilox General Information

Description

Manufacturer of bioceramic materials designed to re-mineralize broken tooth tissues. The company has manufactured a bioceramic powder that consists of materials like calcium phosphate-based micro-spheres that assist in dentistry and medicine, enabling doctors to help patients reduce tooth sensitivity easily.

Contact Information

Website
www.psilox.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Devices and Supplies
Other Industries
Medical Supplies
Biotechnology
Primary Office
  • Vallvägen 4A
  • 754 51 Uppsala
  • Sweden
+46 070-528 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Psilox Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 05-Feb-2018 $625K 00000 00.000 Completed Generating Revenue
4. Accelerator/Incubator 23-Jun-2015 Completed Generating Revenue
3. Early Stage VC 15-Jun-2015 Completed Generating Revenue
2. Grant 01-Sep-2014 $289K Completed Generating Revenue
1. Accelerator/Incubator Completed Startup
To view Psilox’s complete valuation and funding history, request access »

Psilox Patents

  • 22

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 3

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Psilox Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20220296477-A1 Stabilized amorphous calcium magnesium phosphate particle compositions Pending 30-Oct-2019 0000000000
CA-3154892-A1 Stabilized amorphous calcium magnesium phosphate particle compositions Pending 30-Oct-2019 000000000
EP-4051211-A1 Stabilized amorphous calcium magnesium phosphate particle compositions Pending 30-Oct-2019 000000000
JP-2023500630-A Stabilized amorphous calcium magnesium phosphate particle composition Pending 30-Oct-2019 000000000
EP-3166571-A1 Cement systems, hardened cements and implants Active 07-Jul-2014 A61C8/0015
To view Psilox’s complete patent history, request access »

Psilox Executive Team (4)

Name Title Board Seat Contact Info
Tomas Lindström Ph.D Chief Executive Officer
Håkan Engqvist Founder & Executive Chairman
You’re viewing 2 of 4 executive team members. Get the full list »

Psilox Board Members (5)

Name Representing Role Since
Håkan Engqvist Self Founder & Executive Chairman 000 0000
Jesper Dahlberg GU Ventures Board Member 000 0000
Thomas Pollare Ph.D Self Board Member 000 0000
You’re viewing 3 of 5 board members. Get the full list »

Psilox Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Psilox Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almi Invest Venture Capital Minority 000 0000 000000 0
UU Invest Venture Capital Minority 000 0000 000000 0
Vinnova Government Minority 000 0000 000000 0
GU Ventures Venture Capital Minority 000 0000 000000 0
To view Psilox’s complete investors history, request access »

Ready to get started?

Request a free trial